1. Home
  2. NSPR vs HYPR Comparison

NSPR vs HYPR Comparison

Compare NSPR & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • HYPR
  • Stock Information
  • Founded
  • NSPR 2005
  • HYPR 2014
  • Country
  • NSPR United States
  • HYPR United States
  • Employees
  • NSPR N/A
  • HYPR N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • HYPR Medical Specialities
  • Sector
  • NSPR Health Care
  • HYPR Health Care
  • Exchange
  • NSPR Nasdaq
  • HYPR Nasdaq
  • Market Cap
  • NSPR 75.1M
  • HYPR 55.9M
  • IPO Year
  • NSPR N/A
  • HYPR N/A
  • Fundamental
  • Price
  • NSPR $2.24
  • HYPR $0.80
  • Analyst Decision
  • NSPR Strong Buy
  • HYPR Strong Buy
  • Analyst Count
  • NSPR 2
  • HYPR 3
  • Target Price
  • NSPR $4.50
  • HYPR $1.06
  • AVG Volume (30 Days)
  • NSPR 364.9K
  • HYPR 631.1K
  • Earning Date
  • NSPR 08-05-2025
  • HYPR 08-07-2025
  • Dividend Yield
  • NSPR N/A
  • HYPR N/A
  • EPS Growth
  • NSPR N/A
  • HYPR N/A
  • EPS
  • NSPR N/A
  • HYPR N/A
  • Revenue
  • NSPR $7,027,000.00
  • HYPR $11,732,000.00
  • Revenue This Year
  • NSPR $4.85
  • HYPR $12.31
  • Revenue Next Year
  • NSPR $113.47
  • HYPR $29.29
  • P/E Ratio
  • NSPR N/A
  • HYPR N/A
  • Revenue Growth
  • NSPR 8.49
  • HYPR 0.34
  • 52 Week Low
  • NSPR $1.99
  • HYPR $0.53
  • 52 Week High
  • NSPR $3.80
  • HYPR $1.90
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 39.89
  • HYPR 58.62
  • Support Level
  • NSPR $2.12
  • HYPR $0.70
  • Resistance Level
  • NSPR $2.33
  • HYPR $0.77
  • Average True Range (ATR)
  • NSPR 0.16
  • HYPR 0.05
  • MACD
  • NSPR -0.02
  • HYPR 0.00
  • Stochastic Oscillator
  • NSPR 41.67
  • HYPR 93.33

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Share on Social Networks: